[PDF] Top 20 Ética y epistemología de la ecología
Has 4443 "Ética y epistemología de la ecología" found on our website. Below are the top 20 most common "Ética y epistemología de la ecología".
New developments in the treatment of optic neuritis
... and new lesions develop over the course of the year at three months (B), six months (C), and 12 months ...seen. New lesions are seen at six months, with the appearance of a right frontal juxtacortical ... See full document
16
Current options for the treatment of optic neuritis
... Abstract: Optic neuritis can be defined as typical (associated with multiple sclerosis, improving independent of steroid treatment), or atypical (not associated with multiple sclerosis, steroid- ... See full document
8
New developments in the treatment of hyperammonemia: emerging use of carglumic acid
... consists of reducing catabolism and promoting anabolism, by a protein-restriction diet and substituting an oral or intravenous high energy source, such as glucose infusion, and parenteral lipids administration after ... See full document
30
New developments in the treatment of primary biliary cholangitis – role of obeticholic acid
... the treatment of PBC is an important advance for patients who are at an increased risk of liver-related complications despite UDCA therapy or are unable to tolerate ...for treatment with ... See full document
11
New developments in the treatment of metastatic melanoma – role of dabrafenib–trametinib combination therapy
... to drive a treatment choice with dabrafenib and trametinib. However, in a patient of lesser performance status who would be less able to tolerate pyrexia or in a patient who has pre- existing gastrointestinal, ... See full document
16
New developments in the treatment of chronic lymphocytic leukemia: role of obinutuzumab
... Updated analysis of CLL11 with a data cutoff of April 2014 was recently published. As seen in the earlier analysis, the median PFS continued to remain significantly prolonged with G-Clb compared with R-Clb (29.2 vs 15.4 ... See full document
12
Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine
... established treatment concepts of RRMS? Similar to natalizumab, not efficacy data from phase 3 clinical trials, but safety data from still running trials and of a potential post- marketing era, will finally answer ... See full document
14
New developments in the treatment of partial-onset epilepsy
... the treatment of partial seizures in adults resulted in the fol- lowing findings: (1) carbamazepine and phenytoin; (2) sodium valproate; (3) gabapentin, lamotrigine, carbamazepine, phenobarbital, topiramate, and ... See full document
11
New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid
... From both a patient and a public health perspective, access through compassionate use pathways has several restrictions and additional requirements compared with typical routine programmatic use. Compassionate use (also ... See full document
32
New developments in the treatment of rosacea – role of once-daily ivermectin cream
... cream control once daily switched to azelaic acid 15% gel twice daily. In studies 1 and 2, ivermectin 1% cream showed increasing efficacy from week 12 to week 52. In study 1, the percentage of patients with IGA score of ... See full document
7
New developments in the treatment of hypoactive sexual desire disorder – a focus on Flibanserin
... model was the first to explain a women’s sexual response specifically. She described a woman’s sexual response in dynamic nonlinear terms whereby a woman’s sexual response ultimately results in satisfaction. She ... See full document
28
New developments in the treatment of HER2-positive breast cancer
... Another potential benefit of lapatinib may be in the set- ting of metastatic disease to the brain. HER2-positive breast cancers have an increased tendency to metastasize to the brain, possibly because of increased ... See full document
21
New developments in the treatment of multiple myeloma – <br />clinical utility of daratumumab
... myeloma treatment strategies need to be based on the rational combination of synergistic agents, rather than ad hoc combinations of novel agents with proven ...of new drugs, and indeed drug classes, ... See full document
54
Visual function following optic neuritis treatment
... Features of NMO are visual loss caused by damage to the anterior visual sensory pathways and paraplegia caused by damage to the spinal cord. Pain is not a definite feature. No definite pattern of visual field loss is ... See full document
22
New developments in the treatment of chemotherapy-induced neutropenia: focus on balugrastim
... Taken together, the results of the efficacy analysis accounted for the noninferiority of balugrastim treatment over pegfilgrastim. Additionally, no differences in primary and secondary endpoints were found between ... See full document
12
Patients' knowledge and perception on optic neuritis management before and after an information session
... that treatment with corticosteroids improved their final visual ...In optic neuritis, re-gaining vision is a genuine concern for the patient affected and hence may affect the person ’ s adaptation of ... See full document
68
Clinical Profile and Aetiology of Optic Neuritis in Hospital Universiti Sains Malaysia – 5 Years Review
... 73.3% of the patients (30 eyes) have visual acuity 6/60 or worse during presentation. This included 70.0% (20 eyes) who suffered attacks of papillitis, and 83.4% (10 eyes) with signs of retrobulbar ON. All adult patients ... See full document
145
Pediatric optic neuritis
... in conjunction with multifocal inflammatory conditions of the CNS such as acute disseminated encephalomyelitis (ADEM), multiple sclerosis (MS), or neuromyelitis optica (NMO). In the past decade, a number of studies ... See full document
14
AN OVERVIEW ON OPTIC NEURITIS
... on treatment for 2 months, with 7 months being the ...ethambutol-associated optic neuropathy; perhaps because ethambutol depends on the kidneys for excretion 18,19 ...despite treatment with ... See full document
5
Recurrent optic neuritis: clues from a long-term follow up study of recurrent and bilateral optic neuritis patients
... All of our NMO patients had normal cranial MRI results and all had relapsing NMO. Among the four patients that met the criteria for NMO, three were positive for NMO antibodies in their serum. The absence of antibodies in ... See full document
6
Related subjects